Kronik kabızlığı olan çocuklarda çölyak hastalığı taraması akılcı bir yaklaşım mı?

Year 2023, Volume: 22 Issue: 2, 98 - 102, 31.08.2023

Melike Arslan Coşkun Fırat Özkeçeci Deniz Yaprak Necati Balamtekin

https://doi.org/10.17941/agd.1321313

Abstract

Giriş ve Amaç: Kronik kabızlık çocukluk çağında en sık görülen yakınmalardan birisidir ve yüksek sağlık harcamalarına neden olur. Sınırlı sayıda çalışmanın sonuçlarına göre, bazı araştırmacılar ve kılavuzlar kronik kabızlığı olan tüm hastalarda organik nedenlerin dışlanması gerektiğini önerirken, bazı araştırmalar bunun maliyet etkin bir yaklaşım olmadığını savunmaktadır. Kabızlık, çölyak hastalığının başvuru semptomlarından biri olduğundan, organik nedenlerin dışlanması sürecinde kronik kabızlığı olan hastalar çölyak antikorları ile taranabilir. Gereç ve Yöntem: Çalışma kapsamında Gülhane Eğitim ve Araştırma Hastanesi, Çocuk Gastroenteroloji polikliniğine 2017-2020 yılları arasında başvuran kronik kabızlığı olan toplam 1128 hasta geriye dönük olarak değerlendirildi. Çölyak hastalığı açısından serolojik tarama yapılan hasta sayısı 675 (%59.8) idi. Bulgular: Kronik kabızlığı olan hastaların ortalama yaşı 7.8 ± 4.9 yaş (dağılım 1-18) olup 617'si (%54.7) kızdı. Çölyak hastalığı serolojik taraması yapılan 675 hasta içerisinde çölyak antikor pozitifliği oranı %4.7 (n=32) ve biyopsi ile kanıtlanmış çölyak hastalığı oranı %3.3 idi. Bu oran sağlıklı Türk çocuklarındaki çölyak hastalığı prevalansından (%0.45) istatiksel olarak anlamlı düzeyde farklıydı (p < 0.001). Çölyak hastalığı taramasının kronik kabızlığı olan hastalar için toplam fatura ücretleri 37 000 TL olarak hesaplandı. Yeterli bir ulusal hasta bilgi paylaşım ağının olmaması nedeniyle çölyak hastalığı taraması yapılan 675 hastanın 56'sında 2 kez, 9'unda ise 3 kez çölyak antikor panelinin gereksiz yere bakıldığı saptanmış ve bunun sonucunda 3250 TL ek maliyet ortaya çıkmıştır. Sonuç: Çalışmamızın sonuçları, kronik kabızlığı olan hastalarda çölyak hastalığı prevalansının sağlıklı popülasyona göre anlamlı derecede yüksek olduğunu ve tarama maliyetinin çok yüksek olmadığını göstermektedir. Tanı konmayan Çölyak hastalarının kronik sonuçları ve tekrarlayan başvuruları maliyeti artıracağı için kronik kabızlığı olan hastalarda çölyak hastalığı taraması faydalı olacaktır.

Keywords

Çocuk, çölyak hastalığı, kabızlık, tarama

Is screening for celiac disease in children with chronic constipation a rational approach?

Abstract

Background and Aims: Chronic constipation is one of the most common diseases in childhood and results in high health expenditures. Based on the results of a limited number of studies, some researchers and guidelines suggest that organic causes should be excluded in all patients with chronic constipation, while some studies argue that this is not a cost-effective approach. Since constipation is one of the presenting symptoms of celiac disease, patients with chronic constipation may be screened by celiac antibodies in the process of excluding organic causes. Materials and Methods: A total of 1128 patients with chronic constipation who applied to Gülhane Training and Research Hospital, Pediatric Gastroenterology outpatient clinic between 2017 and 2020 were retrospectively evaluated. Screening for celiac disease was determined in 675 (59.8%) patients. Results: The mean age of the patients with chronic constipation was 7.8 ± 4.9 years (range 1-18 years) and 617 (54.7%) of them were girls. The rate of celiac antibody positivity was 4.7% (n=32) in the patients who had celiac disease screening and the rate of biopsy-proven celiac disease was 3.3%. This rate was significantly different from the prevalence of celiac disease (0.45%) in healthy Turkish children (p < 0.001). Total billing fees for patients with constipation were 37,000 TL. However, due to the lack of an adequate national patient information sharing network, it was determined that the celiac disease screening was performed unnecessarily for two times in 56, and three times in 9 of 675 patients that result in an additional cost of 3,250 TL. Conclusion: The results of our study show that the prevalence of celiac disease in patients with chronic constipation is significantly higher than in the healthy population, and the cost of screening is not very high. Celiac disease screening in patients with chronic constipation will be beneficial, as the chronic outcomes and recurrent admissions of undiagnosed celiac patients will increase the cost.

Keywords

Child, celiac disease, constipation, screening

References

• 1. https://www.sbb.gov.tr/wp-content/uploads/2022/06/Genel-Faaliyet-Raporu-2021.pdf
• 2. Timmerman MEW, Trzpis M, Broens PMA. The problem of defecation disorders in children is underestimated and easily goes unrecognized: a cross-sectional study. Eur J Pediatr 2019;178:33-9.
• 3. Koppen IJN, Vriesman MH, Saps M, et al. Prevalence of functional defecation disorders in children: A systematic review and meta-analysis. J Pediatr 2018;198:121-30.
• 4. Chogle A, Saps M. Yield and cost of performing screening tests for constipation in children. Can J Gastroenterol 2013;27:e35-8.
• 5. North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Evaluation and treatment of constipation in children: summary of updated recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2006;43:405-7.
• 6. Tabbers MM, DiLorenzo C, Berger MY, et al; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition; North American Society for Pediatric Gastroenterology.. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr 2014;58:258- 74.
• 7. Balamtekin N, Uslu N, Baysoy G, et al. The presentation of celiac disease in 220 Turkish children.Turk J Pediatr 2010;52:239-44.
• 8. Choung RS, Branda ME, Chitkara D, et al. Longitudinal direct medical costs associated with constipation in women. Aliment Pharmacol Ther 2011;33:251-60.
• 9. Dalgic B, Sarı S, Basturk B, et al. Prevalence of celiac disease in healthy Turkish school children. Am J Gastroenterol 2011;106:1512-7.
• 10. Marsh MN. Gluten, major histocompatibility complex and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity (celiac sprue). Gastroenterology 1992;102:330-54.
• 11. Çakir M, Cezaroğlu S, Çobanoğlu Ü. Celiac disease in children with chronic constipation. Turk J Med Sci 2016;46:651-6.
• 12. El-Salhy M, Mazzawi T, Gundersen D, Hatlebakk JG, Hausken T. The role of peptide YY in gastrointestinal diseases and disorders (review). Int J Mol Med 2013;31:275-82.
• 13. El-Salhy M. Chronic idiopathic slow transit constipation: pathophysiology and management. Colorectal Dis 2003;5:288- 96.
• 14. Dehghani SM, Ehsaei Z, Honar N, Javaherizadeh H. Frequency of celiac disease in children with chronic functional constipation in Shiraz-Iran. Middle East J Dig Dis 2015;7:166-9.
• 15. Akman S, Şahaloğlu Ö, Dalkan C, Bahçeciler NN, Arıkan Ç. Is celiac disease misdiagnosed in children with functional constipation? Turk J Gastroenterol 2018;29:210-4.
• 16. Pelleboer RA, Janssen RL, Deckers-Kocken JM, et al. Celiac disease is overrepresented in patients with constipation. J Pediatr 2012;88:173-6.
• 17. Choung RS, Shah ND, Chitkara D, et al. Direct medical costs of constipation from childhood to early adulthood: A population-based birth cohort study. J Pediatr Gastroenterol Nutr 2011;52:47-54.
• 18. Liem O, Harman J, Benninga M, et al. Health utilization and cost impact of childhood constipation in the United States. J Pediatr 2009;154:258-62.
• 19. Stephens JR, Steiner MJ, DeJong N, et al. Healthcare utilization and spending for constipation in children with versus without complex chronic conditions. J Pediatr Gastroenterol Nutr 2017;64:31-6.
• 20. Ansari H, Ansari Z, Lim T, Hutson JM, Southwell BR. Factors relating to hospitalisation and economic burden of paediatric constipation in the state of Victoria, Australia, 2002-2009. J Paediatr Child Health 2014;50:993-9.
• 21. Norström F, Myléus A, Nordyke K, et al. Is mass screening for coeliac disease a wise use of resources? A health economic evaluation. BMC Gastroenterol 2021;21:159.
• 22. Rubio-Tapia A, Kyle RA, Kaplan EL, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 2009;137:88-93.